Concurrence of inflammatory bowel disease with multiple sclerosis or Hodgkin lymphoma

Eur J Gastroenterol Hepatol. 2023 Dec 1;35(12):1349-1353. doi: 10.1097/MEG.0000000000002657. Epub 2023 Oct 6.

Abstract

Background and aims: Epidemiologic evidence suggests that Hodgkin lymphoma (HL) and multiple sclerosis (MS) share a common set of risk factors with Crohn's disease (CD) and ulcerative colitis (UC). It was hypothesized that such shared risk factors would lead to clustering of the 4 diagnoses in the same patients.

Methods: All patients with HL, MS, CD, or UC were identified in the veterans population from 2016-2020 and the Medicare population from 1986 to 1989. In a case-control study, the observed concurrences amongst these 4 diagnoses were compared with their expected frequencies in the overall veterans or Medicare population during the same time period by calculating odds ratios (OR) with their 95% confidence intervals (CI).

Results: The study included 6 million veterans and 35 million Medicare patients. In the veterans population, inflammatory bowel disease (IBD) was significantly associated with a concurrent diagnosis of HL (OR: 1.40, 95% CI: 1.15-1.71) and MS (1.34, 1.19-1.50). In the Medicare population, IBD was also significantly associated with HL (1.84, 1.07-3.17) and MS (2.31, 1.59-3.35). Similar trends were observed in CD or UC when analyzed separately in both datasets. In the veterans population, adjustment for the potentially confounding influence of ethnicity, sex, and age left all OR values largely unaffected and statistically significant.

Conclusion: The concurrence of IBD with HL or MS could reflect on a common pathway in the etiology or pathogenesis of these 4 diseases.

MeSH terms

  • Aged
  • Case-Control Studies
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / epidemiology
  • Crohn Disease* / complications
  • Crohn Disease* / diagnosis
  • Crohn Disease* / epidemiology
  • Hodgkin Disease* / complications
  • Hodgkin Disease* / epidemiology
  • Humans
  • Inflammatory Bowel Diseases* / epidemiology
  • Medicare
  • Multiple Sclerosis* / complications
  • Multiple Sclerosis* / epidemiology
  • United States / epidemiology